Ryman Healthcare Limited (OTCPK:RYHTY) Q2 2026 Earnings Call November 26, 2025 5:00 PM EST
Company Participants
Naomi James – Chief Executive Officer
Hayden Strickett
Matthew Prior – Chief Financial Officer
Conference Call Participants
Bianca Fledderus – UBS Investment Bank, Research Division
Arie Dekker – Jarden Limited, Research Division
Will Twiss – Forsyth Barr Group Ltd., Research Division
Stephen Ridgewell – Craigs Investment Partners Limited, Research Division
Nick Mar – Macquarie Research
Presentation
Operator
Thank you for standing by, and welcome to the Ryman Healthcare Half Year Results Briefing. [Operator Instructions] I would now like to hand the conference over to Ms. Naomi James, Chief Executive Officer. Please go ahead.
Naomi James
Chief Executive Officer
Good morning, everyone. I’m Naomi James, Chief Executive Officer of Ryman Healthcare. Thank you for joining us for our half year results for the 6 months to 30 September 2025. With me today is Matt Prior, who commenced as Chief Financial Officer on the 31st of July; and Hayden Strickett, our Head of Investor Relations. We’re going to be working to get through the presentation in around 30 minutes to allow time for Q&A before we wrap up at midday. Looking at the agenda, I’ll provide an overview of sales, stock, operations and development before handing to Matt, who will speak to the financials and capital management. And I’ll then provide an update on outlook and strategic priorities before opening up for Q&A.
Hayden Strickett
Starting on Slide 4. As you’ll see from today’s results, we are well on our way to delivering better returns and are doing the things we said we would do when we raised capital at the start of the year. This is the first positive free cash flow result that Ryman has announced in more than a decade. We have made substantial progress towards achieving our cost reduction
Read the full article here
